CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Executive or director change
- 424B7 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice · Executive or director change · Other events
- 4 Gift 10% owner gave 2,000,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- EFFECT Other Notice of Effectiveness
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- S-3 Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
Page 11 of 24 · 479 filings